An article published Online First and in the October edition of The Lancet Oncology reports that the blood-thinning drug nadroparin halves the risk of developing blood clots in ambulatory cancer patients…
An article published Online First and in the October edition of The Lancet Oncology reports that the blood-thinning drug nadroparin halves the risk of developing blood clots in ambulatory cancer patients…
Recent Comments